Health Change in Management: Exyte announces Katrien Verlinden as new President of its Global Business Unit Advanced Technology Facilities April 2, 2025
Health IgniteData Advances Clinical Trial Efficiencies with Successful Deployment at Leading Cancer Center March 31, 2025
Health SCORE analysis of semaglutide 2.4 mg demonstrated risk reduction in cardiovascular events in a real-world setting March 31, 2025
Health Akeso’s 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies March 31, 2025
Health Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD) presented at ACC 2025 March 30, 2025